Will be interesting to see if IMU gets more of a bump during and after its conference today. MASSIVE buy side demand with 220 buyers for 107,568,372 units vs 61 sellers for 26,085,482 units.
Imugene Limited is an immuno-oncology focused biopharmaceutical company. The Company is engaged in the research and development of human epidermal growth factor receptor 2 positive (HER2 +ve), and gastric and breast cancer vaccines. The Company is also engaged in the research, development and commercialization of health technologies. HER-Vaxx is a cancer immunotherapy designed to treat tumors that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers. HER-Vaxx has completed a Phase I clinical trial with over 10 HER-2 positive patients with metastatic breast cancer. It was shown in pre-clinical studies and in one Phase 1 study to stimulate a potent polyclonal antibody response to HER-2/neu. HER-Vaxx has stimulated the production of HER-2 antibodies in early-stage cancer patients enrolled in the initial clinical trial. The Company is also developing mimotope-based immunotherapies against validated and oncology targets.
Imugene Limited is an immuno-oncology focused biopharmaceutical company. The Company is engaged in the research and development of human epidermal growth factor receptor 2 positive (HER2 +ve), and gastric and breast cancer vaccines. The Company is also engaged in the research, development and commercialization of health technologies. HER-Vaxx is a cancer immunotherapy designed to treat tumors that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers. HER-Vaxx has completed a Phase I clinical trial with over 10 HER-2 positive patients with metastatic breast cancer. It was shown in pre-clinical studies and in one Phase 1 study to stimulate a potent polyclonal antibody response to HER-2/neu. HER-Vaxx has stimulated the production of HER-2 antibodies in early-stage cancer patients enrolled in the initial clinical trial. The Company is also developing mimotope-based immunotherapies against validated and oncology targets.
NOT TRADING ADVICE. ALWAYS DO YOUR OWN RESEARCH.
FIND TRAILING STOPS: SuperTrail.io
FIND COINS BREAKING OUT: CoinRaces.cc
MY YOUTUBE TRADINGVIEW TIPS AND TRICKS: bit.ly/3kRW08o
MEXC FOR CRYPTO: bit.ly/47QCeNR
FIND TRAILING STOPS: SuperTrail.io
FIND COINS BREAKING OUT: CoinRaces.cc
MY YOUTUBE TRADINGVIEW TIPS AND TRICKS: bit.ly/3kRW08o
MEXC FOR CRYPTO: bit.ly/47QCeNR